EU Disease Surveillance Innovation

The EU, through the European Centre for Disease Prevention and Control (ECDC), is actively strengthening its disease surveillance capabilities. Recent actions include launching a new monthly mpox surveillance report to provide updated data on Clade I transmission in Europe, ensuring ongoing monitoring of public health risks. The ECDC also continues to issue a MERS-CoV Worldwide Overview, confirming the absence of new cases and maintaining public health security. These initiatives demonstrate a commitment to robust, ongoing monitoring of infectious diseases.

This concerted effort directly benefits European citizens and businesses by providing critical, up-to-date health information. Citizens can access the mpox report for informed personal health decisions, while the stability reported in the MERS-CoV overview contributes to overall public confidence and economic predictability. Businesses, particularly those in travel and healthcare, rely on this transparent data to manage risks and plan operations, fostering a more resilient European economy.

Looking ahead, EU disease surveillance is moving towards innovative, technology-driven solutions. The ECDC is piloting a mobile application for event-based surveillance in partnership with Africa CDC and HISP SA. This project aims to enhance early detection and rapid response to public health threats through improved data collection and information sharing, ultimately strengthening preparedness for future infectious disease outbreaks across participating regions.